Richard Dolan and Dr. Lawrence Steinman Discuss COVID-19 Testing, Protocols and Flattening the Curve in Colombia
https://www.youtube.com/watch?v=-Iv-FZ7kovE
Corporate Update Investor Webinar – August 2020
https://www.youtube.com/watch?v=Yak_h05G4eQ
Corporate Update Investor Webinar – June 2020
https://www.youtube.com/watch?v=W2vSRZFOGdA
QuestCap: Michael McCarthy Part 2
https://www.youtube.com/watch?v=gxBbrE8CoEs
QuestCap: Michael McCarthy Part 1
https://www.youtube.com/watch?v=0YaIOvkbh0U
QuestCap: Dr. Samira Mubareka
https://www.youtube.com/watch?v=5xjwt3UzObM
QuestCap: Lawrence Steinman
https://www.youtube.com/watch?v=OmnbRj1YgJg
QuestCap: Stan Bharti
https://www.youtube.com/watch?v=cZ_j6xNElQo
COVID-19: Sports
https://www.youtube.com/watch?v=CVvb3j4oVAM
COVID-19: Real Estate Impact
https://www.youtube.com/watch?v=X737MFBdIkk
COVID-19: Macroeconomic Policies
https://www.youtube.com/watch?v=VuiKECQh4L4
COVID-19: Economics
https://www.youtube.com/watch?v=I8UTSZ_RK2Q
COVID-19: Myths
https://www.youtube.com/watch?v=0pqntEZTm9k
COVID-19: The Real Deal
https://www.youtube.com/watch?v=KO2OwYV8qDM
Welcome to QuestCap
https://www.youtube.com/watch?v=-fgsjDHyKSQ
Medivolve Signs Agreement to Acquire 100% of Modern Rx LCC, a Las Vegas based Pharmacy
As part of its telehealth strategy, Medivolve has acquired a pharmacy to better serve Collection Sites telehealth patients as the program launches. Further, Medivolve will host an investor webinar Tuesday, March 23rd at 1 pm ET
Collection Sites Launches Operating Partnership To Extend COVID-19 Testing With Besser Brands; Medivolve Closes Noble Bioscience Transaction
Toronto, Ontario, March 2, 2021 — Medivolve Inc. (“Medivolve” or the “Company”) (NEO:MEDV; OTC:COPRF; FRA:4NC) announces the launch of an operating model with Besser Brands in the state of Florida. Under this framework Besser Brands is initially operating 9 Collection Sites locationsunder the Collection Sites branding, where they are responsible for all related operating costs and systems…
Medivolve Cancels Agreement to Acquire Karland Health; Completes Shares for Debt Settlement
Medivolve will host a webinar Monday, February 22nd at 1 pm ET with medical advisor Dr. Glenn Copeland to discuss Collection Sites telehealth strategy.
Medivolve Announces Launch of Investor Awareness Campaign
After successful operational results from its Collection Sites subsidiary, which includes the sale of 73,973 tests at an average price of $96 in January, Medivolve is initiating an investor awareness campaign.
Medivolve Announces Webinar to Discuss Telehealth Strategy
Medivolve will host a webinar Monday, February 22nd at 1 pm ET with medical advisor Dr. Glenn Copeland to discuss Collection Sites telehealth strategy. Further, Tim Shelburn is stepping down from his executive role at Collection Sites.
Medivolve Enters into Agreement to Acquire Karland Health, Enabling its Wholly Owned Subsidiary, Collection Sites, to Expand Services Beyond COVID-19 Testing with Telehealth and Remote Patient Monitoring
Medivolve Also Strengthens its Balance Sheet via Shares for Debt Settlements.
Collection Sites Provides Update With January Sales of 73,973 Tests at an Average Price of $96 per Test
To date Collection Sites has launched a total of 62 sites across its network with additional new openings in Texas, Florida, and North Carolina. Further, Medivolve will host a webinar today, Thursday, February 4th at 1 pm ET.
Medivolve Enters Into Agreement to Acquire 100% of Noble Bioscience Corp. and Its Agency Rights to Nuturell’s COVID- 19 Surface Shield Technology
Nuturell’s non-toxic silver surface shield technology is a COVID-19 disinfectant that convertsinto a protective shield when air dry, killing the coronavirus among other pathogens for up to 90 days after only ~30 seconds of contact. Further, Medivolve will host a webinar Thursday, February 4 th at 1 pm ET.
Medivolve Announces Webinar Introducing Newest Partners: Marvel Diagnostics, Startup Out of UCLA
Medivolve will host a webinar Thursday, February 4th at 1 pm ET. This includes an overview of Collection Sites’ network growth and a presentation from the UCLA researchers behind the Marvel Diagnostics innovative BlowFISH Technology for the detection of the presence of the COVID-19 virus.
Medivolve Announces Investment Into Marvel Diagnostics and Its Non-Invasive Exhaled Breath Diagnostic Technology
Marvel Diagnostics innovative BlowFISH technology offers the potential for a a simple,
inexpensive, non-invasive, massively-deployable, rapid diagnostic or sentinel system for detecting respiratory illness and airborne viral threats.
Collection Sites Continues Expansion With Launch of New COVID-19 Testing Sites in Florida, Virginia and Texas
THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
MEDIVOLVE ANNOUNCES CLOSING OF “BOUGHT DEAL” PRIVATE PLACEMENT
THIS NEWS RELEASE IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES
Medivolve Inc. Pays Tribute to Strategic Advisor Larry King
TORONTO – January 25, 2021 (GLOBE NEWSWIRE) Medivolve, Inc. (“Medivolve”)
(NEO:MEDV; OTC:COPRF; FRA:4NC) released a statement on the passing of its strategic
advisor, Larry King. With great sadness, we honor the death of our advisor and friend.
Collection Sites Announces Partnership with Health and Wellness Expert, Heidi Powell
Collection Sites and Celebrity Heidi Powell Opens Two Covid-19 Testing Centers – Gives Away Free 30-day Subscription to The Transform App and Provides Access to Innovative Fitness and Nutrition Content to Help People Strengthen and Maintain Healthy Bodies